The store will not work correctly when cookies are disabled.
(R)-4-ethyl-9-(2-fluorophenethyl)-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one
ID: ALA4776924
PubChem CID: 118560963
Max Phase: Preclinical
Molecular Formula: C19H27FN2O2
Molecular Weight: 334.44
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCN1CC2(CCN(CCc3ccccc3F)CC2)O[C@H](C)C1=O
Standard InChI: InChI=1S/C19H27FN2O2/c1-3-22-14-19(24-15(2)18(22)23)9-12-21(13-10-19)11-8-16-6-4-5-7-17(16)20/h4-7,15H,3,8-14H2,1-2H3/t15-/m1/s1
Standard InChI Key: LYZONYJDSRWDIH-OAHLLOKOSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
25.5063 -18.7789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5021 -19.5961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2039 -20.0060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9143 -19.6032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.9184 -18.7860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2121 -18.3716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0989 -17.9617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0989 -18.7789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8042 -19.1834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5094 -17.9617 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.8042 -17.5490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8042 -16.7318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3900 -17.5552 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.6193 -20.0164 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3296 -19.6123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0347 -20.0255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0270 -20.8435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7313 -21.2566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4426 -20.8525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4452 -20.0311 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7404 -19.6217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.3927 -19.1890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6840 -18.7822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7431 -18.8045 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 1 0
7 11 1 0
8 9 1 0
9 1 1 0
1 10 1 0
10 11 1 0
11 12 1 1
7 13 2 0
4 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
8 22 1 0
22 23 1 0
21 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.44 | Molecular Weight (Monoisotopic): 334.2057 | AlogP: 2.47 | #Rotatable Bonds: 4 |
Polar Surface Area: 32.78 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.39 | CX LogP: 2.10 | CX LogD: 1.08 |
Aromatic Rings: 1 | Heavy Atoms: 24 | QED Weighted: 0.85 | Np Likeness Score: -0.81 |
References
1. García M,Virgili M,Alonso M,Alegret C,Farran J,Fernández B,Bordas M,Pascual R,Burgueño J,Vidal-Torres A,Fernández de Henestrosa AR,Ayet E,Merlos M,Vela JM,Plata-Salamán CR,Almansa C. (2020) Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ Receptor Antagonist Clinical Candidate for the Treatment of Pain., 63 (24): [PMID:33064947] [10.1021/acs.jmedchem.0c01127] |